Page last updated: 2024-11-03

primaquine and Carcinoma, Squamous Cell

primaquine has been researched along with Carcinoma, Squamous Cell in 1 studies

Primaquine: An aminoquinoline that is given by mouth to produce a radical cure and prevent relapse of vivax and ovale malarias following treatment with a blood schizontocide. It has also been used to prevent transmission of falciparum malaria by those returning to areas where there is a potential for re-introduction of malaria. Adverse effects include anemias and GI disturbances. (From Martindale, The Extra Pharmacopeia, 30th ed, p404)
primaquine : An N-substituted diamine that is pentane-1,4-diamine substituted by a 6-methoxyquinolin-8-yl group at the N(4) position. It is a drug used in the treatment of malaria and Pneumocystis pneumonia.

Carcinoma, Squamous Cell: A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
D'iakonova, MIu1
Sorkin, AD1
Nikol'skiĭ, NN1

Other Studies

1 other study available for primaquine and Carcinoma, Squamous Cell

ArticleYear
[The effect of the lysosomotropic agent primaquine on the endocytosis of the epidermal growth factor receptors in A431 cells].
    Tsitologiia, 1992, Volume: 34, Issue:7

    Topics: Carcinoma, Squamous Cell; Endocytosis; Epidermal Growth Factor; ErbB Receptors; Fluorescent Antibody

1992